Total Results: 491
Perspectives: Expensive Cancer Drugs May Finally Be In For A Little Competition
Read recent commentaries about drug-cost issues.
Author Of New Drug Transparency Law Hopes Rest Of Country Will Follow In California’s Footsteps
News outlets report on stories related to pharmaceutical pricing.
What Do Lawmakers Do When They Need Prescriptions Filled? They Don’t Walk Into The Nearest CVS
It’s a little-known perk, but lawmakers have their pills delivered directly to the Capitol, so they can just walk down and pick them up. That also means the pharmacist in charge of filling the prescriptions knows a lot more about the leaders of the country than most pharmacists know about their customers.
Gottlieb Says He Can Be Most Effective At FDA, But Dodges Question On Nomination Talks
“I feel like I want to continue to follow through on the policies we’ve put out and it’s where I think I can be most effective,” said Food and Drug Administration Commissioner Scott Gottlieb, whose name has been floated as a replacement for former Health and Human Services Secretary Tom Price. Meanwhile, President Donald Trump names an acting secretary for the agency.
10 Years Ago This Lawyer Went Up Against Pharma Over Opioids And Won. Now He’s Ready For Round Two.
Back in 2007, Purdue settled with individual patients who alleged that it had underplayed the addiction risk of its medications. It was a huge case for lawyer Paul Hanly and a rare win against makers of painkillers. Now, in an entirely different landscape — one where these companies are becoming the targets of states who want to try to curb the national crisis — Hanly is gearing up to go again. Meanwhile, PBS looks at how the brain gets addicted to opioids in the first place.
California Governor Signs One Of Strictest Drug Transparency Bills In Nation
The pharmaceutical industry has fought hard to kill the legislation, and it will likely be a legal target now that the bill is law.
New Law Challenges ‘Evils’ Of Pharma Profits, California Governor Claims
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
Drugmakers On Edge As California Governor Expected To Sign Bill To Curb Prices
For pharmaceutical companies, California is seen as a bellwether state that often sets the pace and tone for other legislative efforts around the country.
In Latest Setback, Painkiller-Maker Agrees To Pay $500K In Suit Over Marketing Tactics
Massachusetts brought the lawsuit on claims that the company “aggressively marketed its product and made illegal payments to providers to boost sales.”
New Trial Ordered In Battle Over Cholesterol Drug In Win For Sanofi, Regeneron Over Amgen
A federal appeals court reverses a sales ban on Sanofi and Regeneron’s pricey cholesterol medicine Praluent. In other pharmaceutical industry news, the FDA considers looser safety protocols on compounded drugs.
The Food and Drug Administration says that it is monitoring potential shortages of key medications manufactured on the devastated island. Other health fallout facing Puerto Ricans include mental health concerns, a lack of insurance coverage and not enough clean and drinkable water.
Eyes Fixed On California As Governor Ponders Inking Drug Price Transparency Bill
“If it gets signed by this governor, it’s going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million lobbying against this bill and other drug laws in California.
Viewpoints: Puerto Rico’s Public Health Crisis; Make School Lunches Free; The Noble Fruit Fly
A selection of opinions on health care from around the country.
In Effort To Slow Opioid Epidemic, Cigna Drops Coverage For OxyContin
Instead, the insurer will cover Xtampza ER, which it calls an “oxycodone equivalent with abuse deterrent properties.” In other news on the nation’s drug crisis: federal officials look to Buffalo’s opioid crisis intervention court as a potential model; a Texas county is the latest to sue drug companies for their alleged role in the epidemic; researchers turn to virtual reality for pain solutions; and more.
Early Approval Of Generic MS Drug Signals Big Changes For Teva And Other Drugmakers
Teva had lobbied the Food and Drug Administration to reject Mylan’s generic version of its Copaxone multiple sclerosis medication. In other drug industry news: an experimental drug is found to work on a mutant gene; advocates await Calif. Gov. Jerry Brown’s decision on a drug pricing bill; and Cleveland Clinic’s CEO wants supporters of a drug pricing ballot measure in Ohio to stop using his image.
Hurricane Reveals Just How Much America Relies On Puerto Rico For Its Pharmaceutical Supply
Officials have a real fear that there will be shortages of drugs for maladies such as childhood leukemia and HIV. The island has become one of the world’s biggest centers for pharmaceutical manufacturing. Meanwhile, the threat of illness lingers with the floodwaters even as medical supplies are dwindling.
Perspectives: Cutting Back On Drug Coupons May Save Big Bucks Without Harm To Patients
Read recent commentaries about drug-cost issues.
Tax Reform Plan A Dream Come True For Pharmaceutical Industry
News outlets report on stories related to pharmaceutical pricing.
Más pacientes del Medicaid y presos podrán tratarse con una droga contra la hepatitis C
El tratamiento con una droga aprobada por la Administración de Drogas y Alimentos cuesta menos y cura la hepatitis C en alrededor de dos meses. Pacientes vulnerables tendrían más acceso a esta terapia.
Shire Files Anti-Trust Suit Against Allergan: ‘There Was Not A Level Playing Field’
Shire says it offered discounts to Medicare Part D plans, but the program refused due to Allergan’s “bundled discounts, exclusive dealing” and other tactics.
